Eric B. Kmiec

Eric B. Kmiec

Company: ChristianaCare Gene Editing Institute

Job title: Executive Director & Chief Scientific Officer


Restoring the Efficacy of Chemotherapy: Utilizing CRISPR as a Gene- Disabling Treatment for Squamous Cell Carcinoma of the Lung 4:30 pm

Understanding the science behind disabling the NRF2 gene as a squamous cell carcinoma treatment adjunct Evaluating the efficacy and safety data, and how these are being demonstrated to the regulators to transition to clinical development Exploring the differences and potential benefits in developing a gene editing product in a community-based health systemRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.